Sun Pharmaceutical (SUNPHARMA) — Corporate Action

Sun Pharmaceutical scheduled a Board meeting for 31 January 2026 to approve Q3 FY2026 financial results and consider declaring an interim dividend. If approved, eligible shareholders as of record date 5 February 2026 will receive the dividend. The company noted mandatory tax deduction at source and urged shareholders to update depositary records. Trading window remains closed until 2 February 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this corporate action affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 20 January 2026?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 20 January 2026

SBICARD SBI Cards and Payment Services Limited Financial Results SRF SRF Limited Financial Results SRF SRF Limited Corporate Action SRF SRF Limited Corporate Action SRF SRF Limited Financial Results SRF SRF Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.